Open AccessDapagliflozin for Chronic Kidney Disease
Author(s) -
Sara D. Khangura,
Melissa Severn
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.354
Subject(s) - dapagliflozin , medicine , kidney disease , placebo , renal function , intensive care medicine , adverse effect , diabetes mellitus , randomized controlled trial , clinical trial , disease , type 2 diabetes , alternative medicine , endocrinology , pathology